Skip to content

Advanta 21001

by Atrium Medical Corporation

Ref 21001

Advanta 21001 is a synthetic vascular graft (EU MDD Class IIb; FDA Class II; FDA product code DSY, Prosthesis, Vascular Graft, of 6mm and Greater Diameter) made by Atrium Medical Corporation, registered in EUDAMED on 8 Jun 2026 (Basic UDI-DI B-00650862210019), cleared under FDA 510(k) K231972 on 28 Mar 2024 (1 earlier submission) and listed in FDA GUDID since 24 Sep 2015 (UDI-DI 00650862210019), active as of 22 Oct 2026. 39 FDA recalls are linked to it.

Active European Union and United States. Also listed in GUDID (US).

CE MDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

37 ongoing

This device is named in the recall

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD EUDAMED NumberB-00650862210019 Basic UDI-DI 00650862210019UDI-DIDate8 Jun 2026RegisteredStatusActive
United StatesFDA 510(k)SESE GUDID from GUDID Substantially Equivalent · Traditional NumberK231972 Date28 Mar 2024DecidedStatusActive
United StatesGUDID listing GUDID Number00650862210019 UDI-DI Date24 Sep 2015ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
7MMX10CM, SW, ADVANTA VXT
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI B-00650862210019 registered 8 Jun 2026 Active
  • FDA 510(k) K231972 decided 28 Mar 2024 Active· +1 more in the status table
  • FDA GUDID UDI-DI 00650862210019 listed 24 Sep 2015 Listed

Recalls

39 recalls · 37 ongoing · FDA

  • 37 recalls, same reason

    • Ongoing Z-1982-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1979-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1966-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1968-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1988-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1970-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1987-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1976-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1957-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1971-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1959-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1972-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1980-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1985-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1986-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1960-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1981-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1961-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1955-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1974-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1963-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1991-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1973-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1990-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1956-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1989-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1977-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1975-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1983-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1992-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1965-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1953-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1984-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1978-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1969-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1952-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1967-2024 FDA Class II initiated 3 May 2024

    Complaints of reported separation of the Slider GDS Swivel Rod from the Swivel Core and of a notable gap between the two pieces.

    • Terminated Z-2589-2021 FDA Class II initiated 25 Aug 2021

    The product package may potentially contain a mismatched graft that does not contain the radial support ring (helix) identified in the labeling.

    • Terminated Z-2304-2013 FDA Class II initiated 12 Jul 2013

    Inner tray label may adhere to wall of outer tray which make it difficult to remove the tray onto the sterile field

Timeline

43 dated events

  1. Recall initiated FDA recalls Z-1983-2024
  2. Recall initiated FDA recalls Z-1992-2024
  3. Recall initiated FDA recalls Z-1965-2024
  4. Recall initiated FDA recalls Z-1953-2024
  5. Recall initiated FDA recalls Z-1984-2024
  6. Recall initiated FDA recalls Z-1978-2024
  7. Recall initiated FDA recalls Z-1969-2024
  8. Recall initiated FDA recalls Z-1952-2024
  9. Recall initiated FDA recalls Z-1967-2024
  10. Registered EUDAMED B-00650862210019

33 earlier events are in the sections above.

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Trade name
Advanta VXT Vascular Grafts EUDAMED
Advanta GUDID
Generic name
Synthetic vascular graft, non-medicated
Device name
Advanta Vxt, 7X10, Ngds, Nh, Str-Sw
Model / reference
21001
Primary DI / UDI-DI
00650862210019
Basic UDI-DI
B-00650862210019
510(k) Number
FDA product code
DSY
EMDN code
P070401020103 Ptfe vascular endoprostheses, straight - peripheral
GMDN term
Synthetic vascular graft, non-medicated
Device class
Class IIb EUDAMED
Class II GUDID
Regulation number
870.3450
EU registration type
Legacy device (under a directive)
EU market of registration
Netherlands
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IIb
GUDID
Class II

Device class is stated on each registry's own scale: Class IIb in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under VASCULAR AND CARDIAC PROSTHESES.

Other devices from Atrium Medical Corporation

See all devices from Atrium Medical Corporation →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Serial number
  • Expiration date
Other properties (17, all answered No)